Health Insurance Change - Recensione dipendente - Dipendente anonimo presso T1D Exchange

4,0
1 mag 2025
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Remote work, great co-workers, exemplary work-life balance

Svantaggi

health insurance recently downgraded - new provider

Esplora altre recensioni su T1D Exchange

5,0
10 apr 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Smart and dedicated team with a focus on improving diabetes outcomes.

Svantaggi

Can be difficult working with multiple clinics in the collaborative.

2,0
6 ott 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Salary and decent benefits. Remote work. Quality improvement team is doing some important work.

Svantaggi

Organization harvests data from people with T1D via their registry. While the patient users of this registry may think that their data is going to diabetes research for a cure, in fact it's just going to pharma. Pharma uses this information with the sole goal of improving their bottom line. The CEO of the org makes close to half a mil annually leading a small (under $10 million in annual revenue) nonprofit, which seems awfully high for a person who had no experience leading a charity when he began. I wonder about this place. They get nearly all of their money from pharma selling data and research support. It's lucrative and would seem more appropriate for a for-profit as pharma is their client, not the patient with T1D.

Vedi recensioni per: Utile|Valutazione|Data|Tutto